A demo

10310 Articles Matching "drug"

Lilly cancer drug fails key trial, will no longer be prescribed

Jan 19, 2019 , Reuters
Eli Lilly and Co said on Friday that its cancer treatment Lartruvo, which had won conditional approval, failed to improve patient survival in a long-term confirmatory study and will no longer be prescribed, driving the drugmaker's shares down nearly 3 percent....
Read more

Opioid deaths linked to drug marketing to physicians, study

Jan 19, 2019 , Modern Healthcare Breaking News
New research shows a link between increased opioid marketing to physicians and higher opioid prescribing rates and elevated overdose deaths in the U.S. It's one of the first studies to make that...
Read more

MedPAC members consider arbitration to control drug prices

Jan 19, 2019 , Modern Healthcare Breaking News
Medicare Payment Advisory Commission members say the panel needs to explore how to lower hospitals' drug prices covered under Medicare Part A, with some members floating binding arbitration as a...
Read more

CVS and Walmart resolve short-lived reimbursement dispute

Jan 19, 2019 , Modern Healthcare Breaking News
CVS Health and Walmart said they have resolved a contract dispute and inked a new multiyear contract that allows certain CVS pharmacy benefit management customers to continue filling prescriptions at Walmart...
Read more

Which Came First: Cannabis Use Or Psychotic Disorders? Scientists Weigh In On Dangers, Myths

Jan 19, 2019 , Kaiser Health News
Top scientists who specialize in marijuana research are divided over whether the drug can lead to disorders like schizophrenia. “I’ve been doing this research for 25 years, and it’s polarizing even among academics,” said Margaret Haney, a professor of neurobiology at Columbia University Medical Center. Other public health news focuses on climate change's dangers; pain's origins in the brain; the race for health apps; a video game for kids with ADHD; a new way to tell if patients take...
Read more
Demo

Short Supply, Cost of Key Drugs

Jan 19, 2019 , eMedicine Health
Short Supply, Cost of Key Drugs Leave Hospitals...
Read more

Study: Marketing to Docs, Opioid Crisis Linked

Jan 19, 2019 , WebMD
A county-by-county analysis showed that opioid use increased in places where drug makers focused their marketing efforts to physicians, researchers...
Read more

FDA chief: Agency has money for about 5 more weeks of drug approvals

Jan 19, 2019 , Drug Store News - Retail
FDA commissioner Scott Gottlieb responded to queries about the government shutdown's effect on drug approvals on Twitter. Read More...
Read more

Samsung Bioepis biosimilar to Roche's Herceptin wins FDA nod

Jan 19, 2019 , Reuters
The U.S. Food and Drug Administration said on Friday it had approved a biosimilar to Roche Holding AG's blockbuster breast cancer treatment, Herceptin....
Read more

Short Supply, Cost of Key Drugs Leave Hospitals Scrambling

Jan 19, 2019 , RxList
Major hospital groups on Tuesday highlighted the challenges created by both frequent shortages of critical products, including saline and injectable opioids, and rising prices for medicines, including decades-old generic...
Read more

Azar's reference drug pricing model makes inroads with GOP

Jan 19, 2019 , Modern Healthcare Breaking News
The Trump administration's idea to tie Medicare drug spending to other countries' lower prices is popular with progressive Democrats, but can HHS Secretary Alex Azar bring Senate Republicans on...
Read more
Demo

FDA clears the way to increase access and lower cost of life-saving opioid overdose treatment drug

Jan 18, 2019 , CNBC Health
The FDA's change clears the way for drugmakers to sell naloxone without a prescription. The life-saving treatment for opioids is also known as Narcan and...
Read more

Podcast: KHN’s ‘What The Health?’ Drug Prices Are Rising Again. Is Someone Going To Do Something About It?

Jan 18, 2019 , Kaiser Health News
As drugmakers hike prices, interest to rein them in grows on Capitol Hill. Next week marks the anniversary of Roe v. Wade, the Supreme Court’s abortion decision, and both the House, whose leaders back abortion rights, and the Senate, controlled by abortion foes, are holding statement votes. And the government shutdown is still affecting health programs. Joanne Kenen of Politico, Margot Sanger-Katz of The New York Times and Alice Ollstein of Politico join KHN’s Julie Rovner to discuss these...
Read more

Are Some Opioid Abusers Using Their Pets to Get the Drugs?

Jan 18, 2019 , MedicineNet
Title: Are Some Opioid Abusers Using Their Pets to Get the Drugs?Category: Health NewsCreated: 1/15/2019 12:00:00 AMLast Editorial Review: 1/16/2019 12:00:00...
Read more

Nexus Pharmaceuticals gets FDA OK for generic Busulfex injection

Jan 18, 2019 , Drug Store News - Retail
Nexus Pharmaceuticals' generic Busulfex is the company's second oncology generic drug. Read More...
Read more

FDA advisory panel split over Sanofi-Lexicon diabetes drug

Jan 18, 2019 , Reuters
An advisory panel to the U.S. Food and Drug Administration was divided over whether to recommend approval of a treatment for type 1 diabetes developed by Lexicon Pharmaceuticals Inc and France's Sanofi SA....
Read more

Experimental Drug Could Help In Type 2 Diabetes

Jan 18, 2019 , WebMD
Researchers found that the compound -- dubbed TTP399 for now -- improved patients' blood sugar control when it was added to the standard medication metformin for six...
Read more

Immunomedics' cancer treatment fails to win accelerated approval from the FDA

Jan 18, 2019 , Reuters
Immunomedics Inc said on Thursday the U.S. Food and Drug Administration declined to grant accelerated approval for its breast cancer treatment, sacituzumab....
Read more

FDA gets closer to making naloxone available over the counter

Jan 18, 2019 , Modern Healthcare Breaking News
The Food and Drug Administration is preparing to allow the over-the-counter purchase of the drug overdose-reversal medication naloxone in an effort to expand greater access to the lifesaving...
Read more

Whole Genome Sequencing Method May Speed Personalized Treatment Of Drug-Resistant Infections

Jan 18, 2019 , NewsLine - Healthcare Professionals
Researchers at Johns Hopkins Medicine say they have added to evidence that rapid resistance gene sequencing technology can accurately speed the identification of specific antibiotic-resistant bacteria strains that sicken and kill some patients. A report on a proof of concept study, published in the ......
Read more